Plain-English translation of NCT05477134 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are studying arginine—a natural protein building block your body makes—to understand how it might affect type 2 diabetes in young people. This research will help scientists learn why young people with type 2 diabetes have more aggressive disease than adults, and whether arginine might help improve how the pancreas controls blood sugar.
Type 2 diabetes in young people is increasing rapidly and progresses more aggressively than in adults, but scientists still don't fully understand why. This study aims to uncover whether problems with how the body uses arginine contribute to this disease, which could lead to new treatments.
You likely qualify if…
You likely don't qualify if…
You will complete three study visits. On the first day, you'll receive a stable isotope (a harmless tracer) through an IV and have it infused for 5 hours while researchers measure how your body uses arginine. On the second and third days, you'll drink a glucose solution and have blood tests; on day three, you'll also receive an arginine injection to see how it affects your body's response. The whole process takes place over three separate days.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States